PIEMONTESE, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 237
EU - Europa 218
AS - Asia 134
AF - Africa 1
Totale 590
Nazione #
US - Stati Uniti d'America 236
CN - Cina 85
IE - Irlanda 55
SE - Svezia 40
IT - Italia 38
FI - Finlandia 30
DE - Germania 23
SG - Singapore 21
TR - Turchia 15
AT - Austria 10
ID - Indonesia 7
GB - Regno Unito 6
UA - Ucraina 6
FR - Francia 4
IN - India 3
CZ - Repubblica Ceca 2
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
ES - Italia 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
RO - Romania 1
TW - Taiwan 1
Totale 590
Città #
Chandler 58
Dublin 55
Dearborn 34
Ashburn 18
Singapore 17
Izmir 15
Nanjing 15
Parma 13
Shanghai 12
Boardman 11
Bremen 10
Princeton 10
Vienna 10
Beijing 9
Changsha 6
New York 6
Abbiategrasso 5
Grafing 4
Jacksonville 4
Seattle 4
Shenyang 4
Surabaya 4
Vicenza 4
Villaromagnano 4
Wilmington 4
Zhengzhou 4
Ann Arbor 3
Hebei 3
Hefei 3
Helsinki 3
Nanchang 3
Pune 3
Brno 2
Dallas 2
Denpasar 2
Düsseldorf 2
Guangzhou 2
Jinan 2
Kansas City 2
Los Angeles 2
San Mateo 2
Taiyuan 2
Tianjin 2
Washington 2
Abidjan 1
Bandung 1
Brussels 1
Calamandrana 1
Castiglione Delle Stiviere 1
Chengdu 1
Chicago 1
Des Moines 1
Edinburgh 1
Falls Church 1
Fremont 1
Fuzhou 1
Haikou 1
Hangzhou 1
Jiaxing 1
Jinhua 1
Kunming 1
Madrid 1
Mexico City 1
Miami 1
Munich 1
Ningbo 1
Norwalk 1
Padova 1
Penarth 1
Redmond 1
Redwood City 1
Rho 1
Rockville 1
Rome 1
San Martino in Rio 1
Santa Clara 1
Simi Valley 1
Sofia 1
Suceava 1
Taipei 1
Tokyo 1
Valenzano 1
Totale 420
Nome #
Antiatherogenic effects of ellagic acid and urolithins in vitro 80
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 71
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 66
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 65
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 63
ATTIVITA’ IPOLIPIDEMIZZANTE DEL NUTRACEUTICO OLEACTIV® NEL MODELLO DEL CRICETO GOLDEN SYRIAN 61
Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation. 59
Microbiota intestinale: un nuovo protagonista nella eziologia e nel trattamento dell'aterosclerosi? 55
Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv®, in a Hypercholesterolemia-Induced Golden Syrian Hamster Model 54
Impact of Bifidobacterium bifidum PRL2010 on lipid metabolism in vitro and in vivo 51
Totale 625
Categoria #
all - tutte 2.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202080 0 0 0 0 6 26 26 1 2 16 3 0
2020/202124 0 2 2 9 0 3 2 0 3 1 2 0
2021/202242 0 2 2 4 1 4 1 9 2 2 1 14
2022/2023222 22 26 13 18 22 24 0 9 75 0 8 5
2023/202477 5 7 2 2 5 22 3 3 6 5 1 16
2024/202545 13 14 13 5 0 0 0 0 0 0 0 0
Totale 625